S-Biomedic was the first company to join the JLABS @ BE community in Beerse, Europe. They have recently announced that they are accelerating their commercialization efforts and broadening their development pipeline for cosmetics and dermatology. They have appointed a new CCO, Wesley Carpentier, who will be responsible for overall commercial strategy, expanding S-Biomedic’s business toward new markets and cosmetic applications, thus driving the company’s international growth.
So far 2020 has been a very successful year for S-Biomedic, achieving key milestones with their business partners DSM and Beiersdorf, as well as securing significant research grants. They received funding from the European Union’s Horizon 2020 Research and Innovation program for their commercialization efforts. Additionally, their research pipeline has been supported by the Flanders Innovation and Entrepreneurship agency. Please see their latest press release highlighting how they are growing the company and strengthening both their commercial and research teams. For more information about the company and their research please visit www.sbiomedic.com.